Treatment and delay of outset of synucleinopathic and amyloidogenic disease
US9034337B2 · kind B2 · utility
5Cited by
45References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2007 |
| Grant date | May 19, 2015 |
| Priority date | — |
| Expiry date | Oct 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides improved agents and methods for treatment of diseases associated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the Lewy body. The methods are particularly useful for prophylactic and therapeutic treatment of Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.